logo

Indian News

Share SHARE

asianmarketlow-121517.jpg Asian markets ended mostly weak on Friday, with uncertainty about the outlook for the Republican tax reform plan weighing on investor sentiment.

Marinus-Pharma-121517.jpg 2017 has been an exceptional year for Marinus Pharmaceuticals Inc. (MRNS) as the stock is up an impressive 823% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index (IBB), which has returned just 18% during the same time frame.

Dec14-up-141217.jpg Here's what is making news at GHDX, ARGX and RMTI.

Dec13-up-121317.jpg The following are some of today's top gainers in the pharma/biotech sector.

Pharma-121317.jpg Today's Daily Dose brings you news about Aduro's revised pipeline; FDA approval of a new indication for CoolSculpting; Blueprint's stock offering; encouraging preliminary results from Cellectis' CALM and PALL trials; expanded FDA approval for GlaxoSmithKline's Nucala and Omeros' OMIDRIA.

Dec12-down-121217.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

DEC12-up-121217.jpg Here's why PTI, GLYC and VTL jumped today.

Yescarta-Kymriah-121217.jpg Treatment for cancer patients has undergone a sea change over the past few decades and is still evolving. A brand new therapy for treating cancer to have reached the market is chimeric antigen receptor T-cell (CAR T) therapy, which scientists refer to as a 'living drug'.

Dec-down-121117.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

Dec-up-121117.jpg Here's why ARGX, SNNA, BPMC, and BLUE soared.

Apptio-IR-121117.jpg Shares of Apptio Inc. (APTI), which are up 26% year-to-date, hover near their 52-week high of $24.50 recorded in October.

Follow RTT